Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
NEW YORK, March 10, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Western District of North Carolina on behalf of investors who purchased Babcock & Wilcox Enterprises, Inc. ("Babcock & Wilcox") (NYSE:BW) securities between July 1, 2015 and February 28, 2017.
Click here to learn about the case: http://www.wongesq.com/pslra-sa/babcock-wilcox-enterprises-inc. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (1) although the Company disclosed issues with a single project in its Renewable business segment, it failed to disclose that similar problems were significantly impacting other projects in the same segment; and (2) the Company assured investors that the problems were "a single project issue.”
On February 28, 2017, Babcock & Wilcox announces its fourth quarter and full year 2016 financial results, announcing it lost $71.6 million or $1.47 per share in the fourth quarter. The Company also announced it took charges in the fourth quarter of 2016 resulting from its Renewable business, which reduced margins, and increased its contingencies for several of its Renewable projects. On this news, shares of Babcock & Wilcox fell approximately 37% to close at $10.33 per share on March 1, 2017.
If you suffered a loss in Babcock & Wilcox you have until May 2, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sa/babcock-wilcox-enterprises-inc.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
